Target intelligence / Profile preview

Ribosomal protein L21 pseudogene 130 (RPL21P130)

Target: RPL21P130
Molecular classification: Other (pseudogene), not a receptor, enzyme, transporter, ion channel, transcription factor, etc.

Overview

Ribosomal protein L21 pseudogene 130 (RPL21P130) is a processed, non-coding genomic sequence related to the ribosomal protein L21 gene. Unlike protein-coding ribosomal protein genes, pseudogenes such as RPL21P130 do not encode a functional protein and typically lack biological activity. They are relics of gene duplication events and are dispersed throughout the human genome, often serving no known function. RPL21P130 is used primarily in research contexts such as gene expression and genomics studies, but it is not relevant as a receptor, enzyme, or therapeutic target[5][8][9].

Other names: RPL21_63_1633RPL21P130ribosomal protein L21 pseudogene 130

Mechanism of action

None known—no mechanisms are attributed to drugs acting on this pseudogene.

Biological functions

None known—as a pseudogene, it does not encode a functional protein and has no documented biological function

Disease associations

None known—no documented association with disease for this specific pseudogene. The canonical RPL21 gene is associated with Hypotrichosis simplex, but this is not relevant to the pseudogene

Safety considerations

None known—as a non-coding pseudogene, there are no safety concerns or therapeutic challenges associated.

Interacting drugs

None known—not a drug target, thus no drugs interact with this pseudogene

Biomarkers

None known—RPL21P130 is not used as a biomarker for patient selection or monitoring.

Beyond the preview

Go deeper on Ribosomal protein L21 pseudogene 130 (RPL21P130).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L21 pseudogene 130 (RPL21P130).

Explore the full profile